Try our beta test site
213 studies found for:    HIV [CONDITION] AND ((anti-hiv OR antiretroviral) AND medicines) [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
1 Not yet recruiting The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
Condition: HIV Infection
Intervention: Drug: Anti-HIV Agents
2 Recruiting Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
Condition: HIV Infections
Interventions: Drug: atazanavir/cobicistat;   Drug: darunavir/ritonavir;   Drug: darunavir/cobicistat;   Drug: etravirine;   Drug: elvitegravir/cobicistat;   Drug: dolutegravir;   Drug: tenofovir alafenamide fumarate (TAF);   Drug: TAF/cobicistat;   Drug: TAF/ritonavir;   Drug: efavirenz;   Drug: lopinavir/ritonavir;   Drug: nevirapine;   Drug: rifampicin;   Drug: ethambutol;   Drug: isoniazid;   Drug: pyrazinamide;   Drug: kanamycin;   Drug: amikacin;   Drug: capreomycin;   Drug: moxifloxacin;   Drug: levofloxacin;   Drug: ofloxacin;   Drug: ethionamide/prothionamide;   Drug: terizidone/cycloserine;   Drug: para-aminosalicylic acid (PAS);   Drug: high dose isoniazid (INH);   Drug: bedaquiline;   Drug: clofazamine;   Drug: delamanid;   Drug: linezolid;   Drug: pretomanid;   Drug: atazanavir/ritonavir/tenofovir;   Drug: ethinyl estradiol oral contraceptive;   Drug: etonogestrel implant
3 Recruiting Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical Trial
Condition: HIV
Interventions: Drug: Nevirapine;   Drug: Zidovudine;   Drug: Lamivudine;   Drug: LPV/r
4 Recruiting Youth mHealth Adherence Intervention for HIV+ YMSM
Condition: HIV
Intervention: Device: HIV medication adherence app
5 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
6 Not yet recruiting Evaluation of Neurologic and Psychiatric Adverse Events of Several Antiretroviral Drugs in Real Life Setting
Condition: HIV
Intervention: Drug: prescription of at least one of the following drugs: rilpivirine, elvitegravir, dolutegravir
7 Recruiting Antiretroviral Therapy for Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: HAART;   Drug: Mega-HAART
8 Recruiting Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
Condition: HIV Infections
Interventions: Drug: Lamivudine/zidovudine;   Drug: Efavirenz;   Drug: Raltegravir
9 Recruiting Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
Condition: HIV/AIDS
Intervention:
10 Recruiting Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
Conditions: Tuberculosis;   HIV
Interventions: Drug: 8 hourly LPV/r during TB treatment;   Drug: Nevirapine;   Drug: Lopinavir/Ritonavir
11 Recruiting Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals
Condition: HIV
Intervention: Drug: Enfuvirtide
12 Recruiting CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
Condition: HIV, Inflammation
Interventions: Drug: Assess Safety;   Drug: Effect of drug on viral load;   Drug: Effect of drug on T-cell count;   Drug: Effect of drug on inflammatory biomarkers
13 Recruiting Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals
Condition: HIV
Interventions: Procedure: Upper endoscopy;   Procedure: Anoscopy;   Drug: Truvada
14 Recruiting Dolutegravir in Reservoirs
Condition: HIV
Interventions: Drug: dolutegravir;   Drug: Triumeq;   Drug: Truvada
15 Recruiting Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
Condition: HIV
Interventions: Drug: Dolutegravir;   Drug: Emtricitabine/Tenofovir
16 Recruiting Early ART to Limit Infection and Establishment of Reservoir
Condition: HIV-1 Infection
Intervention: Drug: elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
17 Recruiting Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women.
Conditions: HIV Infections;   Hepatitis B
Intervention:
18 Recruiting Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection
Condition: HIV Infections
Intervention: Drug: Antiretroviral Therapy (Experimental)
19 Recruiting Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
20 Not yet recruiting The Impact and Cost-effectiveness of Safer Conception Strategies for HIV-discordant Couples (SAFER)
Condition: HIV Infections
Interventions: Drug: PrEP (Truvada);   Drug: Antiretrovirals;   Procedure: Semen washing;   Procedure: Artificial vaginal insemination

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.